On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of Cardiology (JACC) on the use of Stereotaxisﾒ robotic technology to treat pulmonary hypertension.

In the study, denervation of the pulmonary arteries was performed using a robotically-navigated ablation catheter. Patients receiving this treatment compared favorably across all efficacy and safety endpoints to those that received a sham procedure and were treated with best pharmaceutical care.